Time Therapeutics Inc. — Form D
Time Therapeutics Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-02. The offering totals $15.0M, of which $12.8M was reported sold. Industry: Other.
Offering
- Filed: 2024-07-02
- Form: D
- Accession: 0001745531-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $12.8M
- Remaining: $2.2M
- Investors: 5
- Date of first sale: 2024-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-517615
Issuer
- Name: Time Therapeutics Inc.
- CIK: 0001745531
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 154 West 14th Street, Suite 6-110, New York, NY, 10010
- Phone: 518-421-8814
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Mohammad Saad Alam | Director | New York, NY |
| Stuart Blitz | Director | New York, NY |
| Theodore Maidenberg | Director | Redwood City, CA |
| Mohammad Saad Alam | Executive Officer | New York, NY |
| Stuart Blitz | Executive Officer | New York, NY |
Other filings by this issuer (7)
More